Literature DB >> 22849721

Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5.

Bruce G Szczepankiewicz1, Han Dai, Karsten J Koppetsch, Dongming Qian, Fan Jiang, Cheney Mao, Robert B Perni.   

Abstract

Carba-NAD is a synthetic compound identical to NAD except for one substitution, where an oxygen atom adjacent to the anomeric linkage bearing nicotinamide is replaced with a methylene group. Because it is inert in nicotinamide displacement reactions, carba-NAD is an unreactive substrate analogue for NAD-consuming enzymes. SIRT3 and SIRT5 are NAD-consuming enzymes that are potential therapeutic targets for the treatment of metabolic diseases and cancers. We report an improved carba-NAD synthesis, including a pyrophosphate coupling method that proceeds in approximately 60% yield. We also disclose the X-ray crystal structures of the ternary complexes of SIRT3 and SIRT5 bound to a peptide substrate and carba-NAD. These X-ray crystal structures provide critical snapshots of the mechanism by which human sirtuins function as protein deacylation catalysts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22849721     DOI: 10.1021/jo301067e

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  18 in total

1.  Structural and functional analysis of human SIRT1.

Authors:  Andrew M Davenport; Ferdinand M Huber; André Hoelz
Journal:  J Mol Biol       Date:  2013-10-10       Impact factor: 5.469

Review 2.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

3.  Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure.

Authors:  Yi Wang; Yi Man Eva Fung; Weizhe Zhang; Bin He; Matthew Wai Heng Chung; Jing Jin; Jing Hu; Hening Lin; Quan Hao
Journal:  Cell Chem Biol       Date:  2017-03-09       Impact factor: 8.116

4.  Chemoenzymatic Preparation of 4'-Thioribose NAD.

Authors:  Xiao-Nan Zhang; Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2019-04-05

Review 5.  Metabolic mechanisms of epigenetic regulation.

Authors:  Jordan L Meier
Journal:  ACS Chem Biol       Date:  2013-11-14       Impact factor: 5.100

6.  carba Nicotinamide Adenine Dinucleotide Phosphate: Robust Cofactor for Redox Biocatalysis.

Authors:  Ioannis Zachos; Manuel Döring; Georg Tafertshofer; Robert C Simon; Volker Sieber
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-10       Impact factor: 15.336

7.  Synthesis of novel N-cyclopentenyl-lactams using the Aubé reaction.

Authors:  Madhuri V Shinde; Rohini S Ople; Ekta Sangtani; Rajesh Gonnade; D Srinivasa Reddy
Journal:  Beilstein J Org Chem       Date:  2015-06-23       Impact factor: 2.883

8.  Crystallographic structure of a small molecule SIRT1 activator-enzyme complex.

Authors:  Han Dai; April W Case; Thomas V Riera; Thomas Considine; Jessica E Lee; Yoshitomo Hamuro; Huizhen Zhao; Yong Jiang; Sharon M Sweitzer; Beth Pietrak; Benjamin Schwartz; Charles A Blum; Jeremy S Disch; Richard Caldwell; Bruce Szczepankiewicz; Christopher Oalmann; Pui Yee Ng; Brian H White; Rebecca Casaubon; Radha Narayan; Karsten Koppetsch; Francis Bourbonais; Bo Wu; Junfeng Wang; Dongming Qian; Fan Jiang; Cheney Mao; Minghui Wang; Erding Hu; Joe C Wu; Robert B Perni; George P Vlasuk; James L Ellis
Journal:  Nat Commun       Date:  2015-07-02       Impact factor: 14.919

9.  Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking.

Authors:  Tobias Rumpf; Stefan Gerhardt; Oliver Einsle; Manfred Jung
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-11-18       Impact factor: 1.056

10.  Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.

Authors:  Tobias Rumpf; Matthias Schiedel; Berin Karaman; Claudia Roessler; Brian J North; Attila Lehotzky; Judit Oláh; Kathrin I Ladwein; Karin Schmidtkunz; Markus Gajer; Martin Pannek; Clemens Steegborn; David A Sinclair; Stefan Gerhardt; Judit Ovádi; Mike Schutkowski; Wolfgang Sippl; Oliver Einsle; Manfred Jung
Journal:  Nat Commun       Date:  2015-02-12       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.